Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after
Surgery

Francesca      Di Candido
Abstract

Inflammatory Bowel Diseases (IBDs) are chronic, relapsing and disabling diseases that affect the gastrointestinal tract. This relapsing course is often unpredictable with severe flares and the need for intensive medical treatment, hospitalization, or emergent/urgent surgery, all of which significantly impact patients’ quality of life (QoL). QoL in IBD patients is significantly lower than in the general population, and depression and anxiety have been shown to have a higher prevalence than in healthy individuals, especially during disease flares. Complications requiring hospitalization and repeated surgeries are not uncommon during the disease course and significantly affect QoL in IBD patients. Patient-reported outcome measures (PROMs) can be used to measure the impact of chronic disease on QoL from the patient’s perspective. The use of PROMs in IBD patients undergoing surgery could help to investigate the impact of the surgical procedure on QoL and determine whether there is any improvement or worsening. This review summarizes the use of PROMs to assess QoL after various surgical procedures required for IBD treatment.
Keywords: Quality of life, inflammatory bowel disease, patient reported, outcome measure, ulcerative colitis, Crohn’s disease, psychological distress.
[1]
Burisch J, Munkholm P,. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol  2015; 50(8): 942-51.
 [http://dx.doi.org/10.3109/00365521.2015.1014407] [PMID: 25687629]

[2]
Levine JS,, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y)  2011; 7(4): 235-41.
 [PMID:  21857821]

[3]
Simian D, Quijada MI, Lubascher J, Acuña R, Quera R. Treatment of inflammatory bowel disease with infliximab: Experience in 25 patients. Rev Med Chil  2013; 141(9): 1158-65.
 [http://dx.doi.org/10.4067/S0034-98872013000900008] [PMID:  24522419]

[4]
Cohen RD. The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther  2002; 16(9): 1603-9.
 [http://dx.doi.org/10.1046/j.1365-2036.2002.01323.x] [PMID:  12197839]

[5]
Rogala L, Miller N, Graff LA, et al. Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease. Inflamm Bowel Dis  2008; 14(4): 526-35.
 [http://dx.doi.org/10.1002/ibd.20353] [PMID:  18183608]

[6]
LeBlanc K, Mosli MH, Parker CE, MacDonald JK. The impact of biological interventions for ulcerative colitis on health-related quality of life. Cochrane Database Syst Rev 2015; (9): CD008655
 [http://dx.doi.org/10.1002/14651858.CD008655.pub3] [PMID:  26393522]

[7]
Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s Colitis  2007; 1(1): 10-20.
 [http://dx.doi.org/10.1016/j.crohns.2007.06.005] [PMID:  21172179]

[8]
Filipovic BR, Filipovic BF. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol  2014; 20(13): 3552-63.
 [http://dx.doi.org/10.3748/wjg.v20.i13.3552] [PMID:  24707138]

[9]
Häuser W, Janke KH,, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis  2011; 17(2): 621-32.
 [http://dx.doi.org/10.1002/ibd.21346] [PMID:  20848528]

[10]
Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm Bowel Dis  2009; 15(7): 1105-8.
 [http://dx.doi.org/10.1002/ibd.20873] [PMID:  19161177]

[11]
Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol  2010; 105(9): 1994-2002.
 [http://dx.doi.org/10.1038/ajg.2010.140] [PMID:  20372115]

[12]
Barnes EL, Kochar B, Long MD, et al. Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database. Inflamm Bowel Dis  2017; 23(6): 875-1.
 [http://dx.doi.org/10.1097/MIB.0000000000001121] [PMID:  28426473]

[13]
Ananthakrishnan AN, Gainer VS, Perez RG, et al. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther  2013; 37(4): 445-54.
 [http://dx.doi.org/10.1111/apt.12195] [PMID:  23289600]

[14]
Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology  1976; 70(3): 439-4.
 [http://dx.doi.org/10.1016/S0016-5085(76)80163-1] [PMID:  1248701]

[15]
Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet  1980; 1(8167): 514.
 [http://dx.doi.org/10.1016/S0140-6736(80)92767-1] [PMID:  6102236]

[16]
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) Patient-reported outcome measures use in medical product development to support labeling claims  2009. Available from
          https://www.fda.gov/down-loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf [Accessed October 10, 2019].

[17]
Mowat C, Cole A, Windsor A, et al. IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut  2011; 60(5): 571-607.
 [http://dx.doi.org/10.1136/gut.2010.224154] [PMID:  21464096]

[18]
Beddy D, Dozois EJ, Pemberton JH. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis  2011; 17(7): 1610-9.
 [http://dx.doi.org/10.1002/ibd.21504] [PMID:  21674718]

[19]
Allison M, Lindsay J, Gould D, Kelly D. Surgery in young adults with inflammatory bowel disease: A narrative account. Int J Nurs Stud  2013; 50(11): 1566-75.
 [http://dx.doi.org/10.1016/j.ijnurstu.2013.04.003] [PMID:  23684395]

[20]
Hahnloser D, Pemberton JH,, Wolff BG,, Larson DR,, Crownhart BS,, Dozois RR. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg  2007; 94(3): 333-40.
 [http://dx.doi.org/10.1002/bjs.5464] [PMID:  17225210]

[21]
Porter ME. What is value in health care? N Engl J Med  2010; 363(26): 2477-81.
 [http://dx.doi.org/10.1056/NEJMp1011024] [PMID:  21142528]

[22]
Bradley SM, Rumsfeld JS, Ho PM. Incorporating health status in routine care to improve health care value: The VA patient reported health status assessment [PROST] system. JAMA  2016; 316(5): 487-8.
 [http://dx.doi.org/10.1001/jama.2016.6495] [PMID:  27483062]

[23]
Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut  2012; 61(2): 241-.
 [http://dx.doi.org/10.1136/gutjnl-2011-300049] [PMID:  21646246]

[24]
Irvine EJ,, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s Relapse Prevention Trial. Am J Gastroenterol  1996; 91(8): 1571-8.
 [PMID:  8759664]

[25]
Yellen SB, Cella DF,, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage  1997; 13(2): 63-74.
 [http://dx.doi.org/10.1016/S0885-3924(96)00274-6] [PMID:  9095563]

[26]
Gower-Rousseau C, Sarter H, Savoye G et al, et al. Validation of the inflammatory bowel disease disability index in a population-based cohort. Gut 2015. Epub ahead of print
 [http://dx.doi.org/10.1136/gutjnl-2015-310151] [PMID:  26646934]

[27]
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand  1983; 67(6): 361-70.
 [http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x] [PMID:  6880820]

[28]
Bewtra M, Brensinger CM, Tomov VT, et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflamm Bowel Dis  2014; 20(6): 1070-8.
 [http://dx.doi.org/10.1097/MIB.0000000000000053] [PMID:  24810138]

[29]
Clara I, Lix LM, Walker JR, et al. The Manitoba IBD Index: Evidence for a new and simple indicator of IBD activity. Am J Gastroenterol  2009; 104(7): 1754-63.
 [http://dx.doi.org/10.1038/ajg.2009.197] [PMID:  19455122]

[30]
Khanna R, Zou G, D’Haens G, et al. A retrospective analysis: The development of patient reported outcome measures for the assessment of Crohn’s disease activity. Aliment Pharmacol Ther  2015; 41(1): 77-86.
 [http://dx.doi.org/10.1111/apt.13001] [PMID:  25348809]

[31]
Bennebroek Evertsz’ F, Hoeks CC, Nieuwkerk PT,, et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn’s disease activity. J Clin Gastroenterol  2013; 47(10): 850-6.
 [http://dx.doi.org/10.1097/MCG.0b013e31828b2196] [PMID:  23632348]

[32]
Bennebroek Evertsz’ F, Nieuwkerk PT,, Stokkers PC,, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohn’s Colitis  2013; 7(11): 890-900.
 [http://dx.doi.org/10.1016/j.crohns.2012.11.007] [PMID:  23269224]

[33]
Van Deen WK, van der Meulen-de Jong AE, Parekh NK, et al. Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies. Clin Gastroenterol Hepatol  2016; 14(12): 1742-1750.e7.
 [http://dx.doi.org/10.1016/j.cgh.2015.10.035] [PMID:  26598228]

[34]
Gürel S, Kiyici M. Ulcerative colitis activity index: A useful prognostic factor for predicting ulcerative colitis outcome. J Int Med Res  2005; 33(1): 103-10.
 [http://dx.doi.org/10.1177/147323000503300111] [PMID:  15651722]

[35]
Pontes RM, Miszputen SJ, Ferreira-Filho OF, Miranda C, Ferraz MB. Quality of life in patients with inflammatory bowel diseases: Translation to Portuguese language and validation of the “Inflammatory Bowel Disease Questionnaire” (IBDQ). Arq Gastroenterol  2004; 41(2): 137-43.
 [http://dx.doi.org/10.1590/S0004-28032004000200014] [PMID:  15543390]

[36]
Alcalá MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis  2004; 10(4): 383-91.
 [http://dx.doi.org/10.1097/00054725-200407000-00009] [PMID:  15475746]

[37]
López-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn’s disease. Digestion  1999; 60(3): 274-80.
 [http://dx.doi.org/10.1159/000007670] [PMID:  10343142]

[38]
Eypasch E, Wood-Dauphinée S, Williams JI, Ure B, Neugebauer E, Troidl H. The gastrointestinal quality of life index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg  1993; 64(4): 264-74.
 [PMID:  8482141]

[39]
Kiran RP, Delaney CP, Senagore AJ, et al. Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn’s disease. Am J Gastroenterol  2003; 98(8): 1783-9.
 [http://dx.doi.org/10.1111/j.1572-0241.2003.07592.x] [PMID:  12907333]

[40]
Ware JEJ, Snow KK, Kosinski M. SF-36 Health Survey: Manual and interpretation guideBoston, MA. The Health Institute, New England Medical Center 1993.

[41]
Van Assche G, Peyrin-Biroulet L, Sturm A, et al. Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months-Multicenter European cohort study. Dig Liver Dis  2016; 48(6): 592-600.
 [http://dx.doi.org/10.1016/j.dld.2016.01.011] [PMID:  26935454]

[42]
Ciconelli RM, Soárez PC,, Kowalski CC, Ferraz MB. The Brazilian Portuguese version of the work productivity and activity impairment: General Health (WPAI-GH) Questionnaire. Sao Paulo Med J  2006; 124(6): 325-32.
 [http://dx.doi.org/10.1590/S1516-31802006000600005] [PMID:  17322953]

[43]
Lerdal A, Wahl A, Rustøen T, Hanestad BR, Moum T. Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health  2005; 33(2): 123-30.
 [http://dx.doi.org/10.1080/14034940410028406] [PMID:  15823973]

[44]
Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry  2003; 25(4): 277-83.
 [http://dx.doi.org/10.1016/S0163-8343(03)00043-4] [PMID:  12850660]

[45]
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res  1989; 28(2): 193-213.
 [http://dx.doi.org/10.1016/0165-1781(89)90047-4] [PMID:  2748771]

[46]
Papi C, Festa V, Fagnani C, et al. Evolution of clinical behaviour in Crohn’s disease: Predictive factors of penetrating complications. Dig Liver Dis  2005; 37(4): 247-53.
 [http://dx.doi.org/10.1016/j.dld.2004.10.012] [PMID:  15788208]

[47]
Louis E, Reenaers C, Belaiche J. Does the behavior of Crohn’s disease change over time? Inflamm Bowel Dis  2008; 14 (Suppl. 2): S54-5.
 [http://dx.doi.org/10.1097/00054725-200810001-00028] [PMID:  18816690]

[48]
Lakatos PL,, Czegledi Z, Szamosi T, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World J Gastroenterol  2009; 15(28): 3504-10.
 [http://dx.doi.org/10.3748/wjg.15.3504] [PMID:  19630105]

[49]
Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn’s disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis  2000; 6(1): 8-15.
 [http://dx.doi.org/10.1097/00054725-200002000-00002] [PMID:  10701144]

[50]
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol  2005; 19 (Suppl. A): 5-36.

[51]
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis  2018; 24(4): 742-51.
 [http://dx.doi.org/10.1093/ibd/izx100] [PMID:  29562277]

[52]
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis  2018; 24(5): 966-76.
 [http://dx.doi.org/10.1093/ibd/izy015] [PMID:  29688466]

[53]
Cosnes J, Gower–Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology  2011; 140(6): 1785-94.
 [http://dx.doi.org/10.1053/j.gastro.2011.01.055]

[54]
Louis E, Reenaers C, Belaiche J. Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn’s disease? Inflamm Bowel Dis  2008; 14 (Suppl. 2): S59-60.
 [http://dx.doi.org/10.1097/00054725-200810001-00031] [PMID:  18816759]

[55]
Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: A cross-sectional study of 361 patients in Southern Italy. Eur J Gastroenterol Hepatol  2015; 27(2): 175-81.
 [http://dx.doi.org/10.1097/MEG.0000000000000244] [PMID:  25461228]

[56]
Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: A new measure of health status. Psychosom Med  1991; 53(6): 701-12.
 [http://dx.doi.org/10.1097/00006842-199111000-00010] [PMID:  1758953]

[57]
de Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: Results from a clinical population. Am J Gastroenterol  2001; 96(6): 1816-21.
 [http://dx.doi.org/10.1016/S0002-9270(01)02440-6] [PMID:  11419835]

[58]
Bączyk G, Formanowicz D, Gmerek Ł, Krokowicz P. Health-related quality of life assessment among patients with inflammatory bowel diseases after surgery-review. Prz Gastroenterol  2017; 12(1): 6-16.
 [http://dx.doi.org/10.5114/pg.2016.64037] [PMID:  28337230]

[59]
Casellas F, López-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn’s disease on health-related quality of life. Am J Gastroenterol  2000; 95(1): 177-82.
 [http://dx.doi.org/10.1111/j.1572-0241.2000.01681.x] [PMID:  10638579]

[60]
Jones DW, Finlayson SR. Trends in surgery for Crohn’s disease in the era of infliximab. Ann Surg  2010; 252(2): 307-12.
 [http://dx.doi.org/10.1097/SLA.0b013e3181e61df5] [PMID:  20585239]

[61]
Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: A patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis  2014; 20(3): 545-52.
 [http://dx.doi.org/10.1097/01.MIB.0000440983.86659.81] [PMID:  24407484]

[62]
Lesperance K, Martin MJ, Lehmann R, Brounts L, Steele SR. National trends and outcomes for the surgical therapy of ileocolonic Crohn’s disease: A population-based analysis of laparoscopic vs. open approaches. J Gastrointest Surg  2009; 13(7): 1251-9.
 [http://dx.doi.org/10.1007/s11605-009-0853-3] [PMID:  19301075]

[63]
Delaney CP, Kiran RP, Senagore AJ, et al. Quality of life improves within 30 days of surgery for Crohn’s disease. J Am Coll Surg  2003; 196(5): 714-21.
 [http://dx.doi.org/10.1016/S1072-7515(03)00131-5] [PMID:  12742203]

[64]
Eshuis EJ, Polle SW, Slors JF, et al. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn’s disease: A comparative study. Dis Colon Rectum  2008; 51(6): 858-67.
 [http://dx.doi.org/10.1007/s10350-008-9195-6] [PMID:  18266036]

[65]
Scarpa M, Ruffolo C, D’Incà R, et al. Health-related quality of life after ileocolonic resection for Crohn’s disease: Long-term results. Inflamm Bowel Dis  2007; 13(4): 462-9.
 [http://dx.doi.org/10.1002/ibd.20080] [PMID:  17206691]

[66]
Ha FJ, Thong L, Khalil H. Quality of Life after Intestinal Resection in Patients with Crohn Disease: A Systematic Review. Dig Surg  2017; 34(5): 355-63.
 [http://dx.doi.org/10.1159/000453590] [PMID:  28099962]

[67]
Wright EK, Kamm MA, De Cruz P, et al. Effect of intestinal resection on quality of life in Crohn’s disease. J Crohn’s Colitis  2015; 9(6): 452-62.
 [http://dx.doi.org/10.1093/ecco-jcc/jjv058] [PMID:  25855073]

[68]
D’Ugo S, Romano F, Sibio S, et al. Impact of surgery on quality of life in Crohn’s disease: Short-and mid-term follow-up Updates Surg  2020; 72(3): 773-80.
 [http://dx.doi.org/10.1007/s13304-020-00738-1] [PMID:  32185677]

[69]
Diederen K, de Ridder L, van Rheenen P, et al. Quality of life and colorectal function in Crohn’s disease patients that underwent ileocecal resection during childhood. Eur J Pediatr  2019; 178(9): 1413-21.
 [http://dx.doi.org/10.1007/s00431-019-03427-3] [PMID:  31327075]

[70]
Gajendran M, Bauer AJ, Buchholz BM, et al. Ileocecal anastomosis type significantly influences long-term functional status, quality of life, and healthcare utilization in postoperative Crohn’s Disease patients independent of inflammation recurrence. Am J Gastroenterol  2018; 113(4): 576-83.
 [http://dx.doi.org/10.1038/ajg.2018.13] [PMID:  29610509]

[71]
McClane SJ, Rombeau JL. Anorectal Crohn’s disease. Surg Clin North Am  2001; 81(1): 169-83. ix.
 [http://dx.doi.org/10.1016/S0039-6109(05)70279-6] [PMID: 11218163]

[72]
Adamina M, Bonovas S, Raine T, et al. ECCO guidelines on therapeutics in Crohn’s Disease: Surgical treatment. J Crohn’s Colitis  2020; 14(2): 155-68.
 [http://dx.doi.org/10.1093/ecco-jcc/jjz187] [PMID:  31742338]

[73]
Tekkis PP, Purkayastha S, Lanitis S, et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn’s disease: A meta-analysis. Colorectal Dis  2006; 8(2): 82-90.
 [http://dx.doi.org/10.1111/j.1463-1318.2005.00903.x] [PMID:  16412066]

[74]
Andersson P, Olaison G, Hallböök O, Sjödahl R. Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum  2002; 45(1): 47-53.
 [http://dx.doi.org/10.1007/s10350-004-6113-4] [PMID:  11786764]

[75]
Kiran RP, Nisar PJ,, Church JM, Fazio VW. The role of primary surgical procedure in maintaining intestinal continuity for patients with Crohn’s colitis. Ann Surg  2011; 253(6): 1130-5.
 [http://dx.doi.org/10.1097/SLA.0b013e318212b1a4] [PMID:  21394010]

[76]
Geoghegan JG, Carton E, O’Shea AM, et al. Crohn’s colitis: The fate of the rectum. Int J Colorectal Dis  1998; 13(5-6): 256-9.
 [http://dx.doi.org/10.1007/PL00013741] [PMID:  9870172]

[77]
Harling H, Hegnhøj J, Rasmussen TN, Jarnum S. Fate of the rectum after colectomy and ileostomy for Crohn’s colitis. Dis Colon Rectum  1991; 34(10): 931-5.
 [http://dx.doi.org/10.1007/BF02049711] [PMID:  1914729]

[78]
American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn’s disease. Gastroenterology  2003; 125(5): 1503-7.
 [PMID:  14598267]

[79]
Siassi M, Weiger A, Hohenberger W, Kessler H. Changes in surgical therapy for Crohn’s disease over 33 years: A prospective longitudinal study. Int J Colorectal Dis  2007; 22(3): 319-24.
 [http://dx.doi.org/10.1007/s00384-006-0150-5] [PMID:  16733647]

[80]
Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: Analysis of outcome and quality of life in 3707 patients. Ann Surg  2013; 257(4): 679-85.
 [http://dx.doi.org/10.1097/SLA.0b013e31827d99a2] [PMID:  23299522]

[81]
Li Y, Stocchi L, Mu X, Cherla D, Remzi FH. Long-term Outcomes of Sphincter-Saving Procedures for Diffuse Crohn’s Disease of the Large Bowel. Dis Colon Rectum  2016; 59(12): 1183-90.
 [http://dx.doi.org/10.1097/DCR.0000000000000706] [PMID:  27824704]

[82]
Lavryk OA, Hull TL. Comparison of long-term outcomes of primary and redo IPAA for patients with Crohn’s disease. Int J Colorectal Dis  2019; 34(11): 1945-51.
 [http://dx.doi.org/10.1007/s00384-019-03411-1] [PMID:  31667589]

[83]
Kock NG. Intra-abdominal “reservoir” in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal “continence” in five ileostomy patients. Arch Surg  1969; 99(2): 223-31.
 [http://dx.doi.org/10.1001/archsurg.1969.01340140095014] [PMID:  5794896]

[84]
Aytac E, Dietz DW, Ashburn J, Remzi FH. Long-term outcomes after continent ileostomy creation in patients with Crohn’s Disease. Dis Colon Rectum  2017; 60(5): 508-13.
 [http://dx.doi.org/10.1097/DCR.0000000000000815] [PMID:  28383450]

[85]
Ingle SB, Loftus EV Jr. The natural history of perianal Crohn’s disease. Dig Liver Dis  2007; 39(10): 963-9.
 [http://dx.doi.org/10.1016/j.dld.2007.07.154] [PMID:  17720635]

[86]
Singh B. McC Mortensen NJ, Jewell DP, George B. Perianal Crohn’s disease. Br J Surg  2004; 91(7): 801-14.
 [http://dx.doi.org/10.1002/bjs.4613] [PMID:  15227686]

[87]
Riss S, Schwameis K, Mittlböck M, et al. Sexual function and quality of life after surgical treatment for anal fistulas in Crohn’s disease. Tech Coloproctol  2013; 17(1): 89-94.
 [http://dx.doi.org/10.1007/s10151-012-0890-x] [PMID:  22956209]

[88]
Maconi G, Gridavilla D, Viganò C, et al. Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission. Int J Colorectal Dis  2014; 29(10): 1285-90.
 [http://dx.doi.org/10.1007/s00384-014-1935-6] [PMID:  24986138]

[89]
Irvine EJ. Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group J Clin Gastroenterol  1995; 20(1): 27-32.
 [http://dx.doi.org/10.1097/00004836-199501000-00008] [PMID:  7884173]

[90]
Adegbola SO, Dibley L, Sahnan K, et al. Burden of disease and adaptation to life in patients with Crohn’s perianal fistula: A qualitative exploration. Health Qual Life Outcomes  2020; 18(1): 370.
 [http://dx.doi.org/10.1186/s12955-020-01622-7] [PMID:  33218361]

[91]
Adegbola SO, Dibley L, Sahnan K, et al. Development and initial psychometric validation of a patient-reported outcome measure for Crohn’s perianal fistula: The Crohn’s Anal Fistula Quality of Life (CAF-QoL) scale. Gut 2020.
 [http://dx.doi.org/10.1136/gutjnl-2019-320553]

[92]
Nordin K, Påhlman L, Larsson K, Sundberg-Hjelm M, Lööf L. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol  2002; 37(4): 450-7.
 [http://dx.doi.org/10.1080/003655202317316097] [PMID:  11989837]

[93]
Abdalla MI, Sandler RS, Kappelman MD, et al. The Impact of Ostomy on Quality of Life and Functional Status of Crohn’s Disease Patients. Inflamm Bowel Dis  2016; 22(11): 2658-64.
 [http://dx.doi.org/10.1097/MIB.0000000000000930] [PMID:  27661669]

[94]
Jansen F, van Uden-Kraan CF, Braakman JA, van Keizerswaard PM,, Witte BI, Verdonck-de Leeuw IM. A mixed-method study on the generic and ostomy-specific quality of life of cancer and non-cancer ostomy patients. Support Care Cancer  2015; 23(6): 1689-97.
 [http://dx.doi.org/10.1007/s00520-014-2528-1] [PMID:  25430480]

[95]
Dibley L, Czuber-Dochan W, Wade T, et al. Members of the stoma PPI team. Patient decision-making about emergency and planned stoma surgery for IBD: A Qualitative exploration of patient and clinician perspectives. Inflamm Bowel Dis  2018; 24(2): 235-46.
 [http://dx.doi.org/10.1093/ibd/izx043] [PMID:  29361098]

[96]
Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol  2017; 15(6): 857-63.
 [http://dx.doi.org/10.1016/j.cgh.2016.10.039] [PMID:  27856364]

[97]
Molodecky NA, Soon IS, Rabi DM,, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology  2012; 142: 46-54.
 [http://dx.doi.org/10.1053/j.gastro.2011.10.001]

[98]
Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology  2012; 143: 1179-87.

[99]
Jairath V, Khanna R, Zou GY, et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther  2015; 42(10): 1200-10.
 [http://dx.doi.org/10.1111/apt.13408] [PMID:  26388424]

[100]
Yarlas A, Rubin DT, Panés J, et al. Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey. J Crohn’s Colitis  2018; 12(5): 600-9.
 [http://dx.doi.org/10.1093/ecco-jcc/jjy024] [PMID:  29718244]

[101]
Bohl JL, Sobba K. Indications and options for surgery in ulcerative colitis. Surg Clin North Am  2015; 95(6): 1211-32. vi.
 [http://dx.doi.org/10.1016/j.suc.2015.07.003 ] [PMID: 26596923]

[102]
Peyrin-Biroulet L, Germain A, Patel AS, Lindsay JO. Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis. Aliment Pharmacol Ther  2016; 44(8): 807-16.
 [http://dx.doi.org/10.1111/apt.13763] [PMID: 27534519]

[103]
Scarpa M, Ruffolo C, Boetto R, Pozza A, Sadocchi L, Angriman I. Diverting loop ileostomy after restorative proctocolectomy: Predictors of poor outcome and poor quality of life. Colorectal Dis  2010; 12(9): 914-20.
 [http://dx.doi.org/10.1111/j.1463-1318.2009.01884.x] [PMID:  19508537]

[104]
Heikens JT, de Vries J, van Laarhoven CJ. Quality of life, health-related quality of life and health status in patients having restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: A systematic review. Colorectal Dis  2012; 14(5): 536-44.
 [http://dx.doi.org/10.1111/j.1463-1318.2010.02538.x] [PMID:  21176062]

[105]
Lightner AL, Mathis KL, Dozois EJ, et al. Results at Up to 30 Years After Ileal Pouch-Anal anastomosis for chronic ulcerative colitis. Inflamm Bowel Dis  2017; 23(5): 781-90.
 [http://dx.doi.org/10.1097/MIB.0000000000001061] [PMID:  28301429]

[106]
Leowardi C, Hinz U, Tariverdian M, et al. Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis. Langenbecks Arch Surg  2010; 395(1): 49-56.
 [http://dx.doi.org/10.1007/s00423-009-0479-7] [PMID:  19280217]

[107]
McKenna NP, Mathis KL, Pemberton JH, Lightner AL. The Impact of age at time of ileal pouch anal anastomosis on short and long-term outcomes in adults. Inflamm Bowel Dis  2018; 24(8): 1857-65.
 [http://dx.doi.org/10.1093/ibd/izy087] [PMID:  29718243]

[108]
Kjaer MD, Laursen SB, Qvist N, Kjeldsen J, Poornoroozy PH. Sexual function and body image are similar after laparoscopy-assisted and open ileal pouch-anal anastomosis. World J Surg  2014; 38(9): 2460-5.
 [http://dx.doi.org/10.1007/s00268-014-2557-4] [PMID:  24711157]

[109]
Browne C, Shaikh F, Iqbal N, McGovern B, Rowe S, Neary P. Quality of life, continence and frequency of pouchitis following laparoscopic versus open colectomy and ileal pouch-anal anastomosis: An Irish perspective. Ir J Med Sci  2015; 184(3): 655-8.
 [http://dx.doi.org/10.1007/s11845-014-1233-x] [PMID:  25422064]

[110]
Hicks CW, Hodin RA, Savitt L, Bordeianou L. Does intramesorectal excision for ulcerative colitis impact bowel and sexual function when compared with total mesorectal excision? Am J Surg  2014; 208(4): 499-504.e4.
 [http://dx.doi.org/10.1016/j.amjsurg.2014.05.012] [PMID:  25124292]

[111]
Lee GC, Deery SE, Kunitake H, et al. Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis. Int J Colorectal Dis  2019; 34(3): 491-9.
 [http://dx.doi.org/10.1007/s00384-018-03221-x] [PMID:  30610435]

[112]
Ishii H, Kawai K, Hata K, et al. Comparison of functional outcomes of patients who underwent hand-sewn or stapled ileal pouch-anal anastomosis for ulcerative colitis. Int Surg  2015; 100(7-8): 1169-76.
 [http://dx.doi.org/10.9738/INTSURG-D-15-00012.1] [PMID:  26595489]

[113]
Lavryk OA, Hull TL, Duraes LC, et al. Outcomes of ileal pouch-anal anastomosis without primary diverting loop ileostomy if postoperative sepsis develops. Tech Coloproctol  2018; 22(1): 37-44.
 [http://dx.doi.org/10.1007/s10151-017-1737-2] [PMID:  29285681]

[114]
Lorenzo G, Maurizio C, Maria LP, et al. Ileal pouch-anal anastomosis 20 years later: Is it still a good surgical option for patients with ulcerative colitis? Int J Colorectal Dis  2016; 31(12): 1835-43.
 [http://dx.doi.org/10.1007/s00384-016-2657-8] [PMID:  27682647]

[115]
Scoglio D, Ahmed Ali U, Fichera A. Surgical treatment of ulcerative colitis: Ileorectal vs ileal pouch-anal anastomosis. World J Gastroenterol  2014; 20(37): 13211-8.
 [http://dx.doi.org/10.3748/wjg.v20.i37.13211] [PMID:  25309058]

[116]
da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg  2010; 97(1): 65-9.
 [http://dx.doi.org/10.1002/bjs.6809] [PMID:  20013930]

[117]
Abdalla M, Norblad R, Olsson M, et al. Anorectal function after ileo-rectal anastomosis is better than pelvic pouch in selected ulcerative colitis patients. Dig Dis Sci  2020; 65(1): 250-9.
 [http://dx.doi.org/10.1007/s10620-019-05757-6] [PMID:  31372911]

[118]
Tonelli F, Di Martino C, Giudici F. Could total colectomy with ileorectal anastomosis be an alternative to total proctocolectomy with ileal pouch-anal anastomosis in selected ulcerative colitis patients? Gastroenterol Res Pract 2016.20165832743
 [http://dx.doi.org/10.1155/2016/5832743] [PMID:  27843448]

[119]
de Buck van Overstraeten A, Brar MS, Khorasani S, Dossa F, Myrelid P. Ileorectal anastomosis versus IPAA for the surgical treatment of ulcerative colitis: A markov decision analysis. Dis Colon Rectum  2020; 63(9): 1276-84.
 [http://dx.doi.org/10.1097/DCR.0000000000001686] [PMID:  32472777]

[120]
Aytac E, Ashburn J, Dietz DW. Is there still a role for continent ileostomy in the surgical treatment of inflammatory bowel disease? Inflamm Bowel Dis  2014; 20(12): 2519-.
 [http://dx.doi.org/10.1097/MIB.0000000000000160] [PMID:  25222659]

[121]
Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol  2016; 22(3): 895-905.
 [http://dx.doi.org/10.3748/wjg.v22.i3.895] [PMID:  26811635]

[122]
Dixon LJ, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis  2015; 21(4): 912-22.
 [http://dx.doi.org/10.1097/MIB.0000000000000289] [PMID:  25581832]

[123]
Uranga JA, López-Miranda V, Lombó F, Abalo R. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol Rep  2016; 68(4): 816-26.
 [http://dx.doi.org/10.1016/j.pharep2.16.05.002] [PMID: 27267792]

[124]
Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, et al. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev  2019; 2(2)CD012839
 [http://dx.doi.org/10.1002/14651858.CD012839.pub2] [PMID:  30736095]

[125]
Malinowski B, Wiciński M, Sokołowska MM, Hill NA, Szambelan M. The rundown of dietary supplements and their effects on inflammatory bowel disease-a review. Nutrients  2020; 12(5): 1423.
 [http://dx.doi.org/10.3390/nu12051423] [PMID:  32423084]

[126]
Dong J, Chen Y, Tang Y, et al. Body mass index is associated with inflammatory Bowel Disease: A systematic review and meta-analysis. PLoS One  2015; 10(12)e0144872
 [http://dx.doi.org/10.1371/journal.pone.0144872] [PMID:  26658675]

[127]
Fink C, Karagiannides I, Bakirtzi K, Pothoulakis C. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis  2012; 18(8): 1550-7.
 [http://dx.doi.org/10.1002/ibd.22893] [PMID:  22407798]

[128]
Biedermann L, Mwinyi J, Scharl M, et al. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis-an open pilot study. J Crohn’s Colitis  2013; 7(4): 271-9.
 [http://dx.doi.org/10.1016/j.crohns.2012.07.010] [PMID:  22883440]

[129]
Burke DA, Axon AT. Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol  1987; 40(7): 782-6.
 [http://dx.doi.org/10.1136/jcp4,.7.782] [PMID:  3305586]

[130]
Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn’s disease. Dig Dis Sci  1997; 42(4): 817-22.
 [http://dx.doi.org/10.1023/A:1018876400528] [PMID:  9125655]

[131]
Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol  2017; 14(8): 491-502.
 [http://dx.doi.org/10.1038/nrgastro.2017.75]

[132]
Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol  2018; 233(3): 2091-103.
 [http://dx.doi.org/10.1002/jcp2,911] [PMID:  28294322]

[133]
Derwa Y, Gracie DJ, Hamlin PJ,, Ford AC. Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther  2017; 46(4): 389-400.
 [http://dx.doi.org/10.1111/apt.14203] [PMID: 28653751]

[134]
Fedorak RN, Feagan BG, Hotte N, et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease. Clin Gastroenterol Hepatol  2015; 13(5): 928-35.e2.
 [http://dx.doi.org/10.1016/j.cgh.2014.10.031] [PMID:  25460016]

[135]
Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology  2003; 124(5): 1202-9.
 [http://dx.doi.org/10.1016/S0016-5085(03)00171-9] [PMID:  12730861]

[136]
Rufino MN, da Costa AL, Jorge EN, et al. Synbiotics improve clinical indicators of ulcerative colitis: Systematic review with meta-analysis. Nutr Rev  2022; 80(2): 157-64.
 [http://dx.doi.org/10.1093/nutrit/nuab017] [PMID:  34010402]

[137]
Kaur L, Gordon M, Baines PA,, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev  2020; 3(3)CD005573
 [http://dx.doi.org/10.1002/14651858.CD005573.pub3] [PMID:  32128795]
Cite As
Reviews on Recent Clinical Trials

Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery

Abstract
